Eli Lilly and Company's Revenue by Segment
In fiscal year 2024, Eli Lilly and Company's revenue by segment (products & services) are as follows:
- Collaboration and Other Revenue: $4.29 B
- Product: $40.75 B
Learn more about Eli Lilly and Company’s Revenue by Geography
Check out competitors to Eli Lilly and Company in a side-by-side comparison.
Explore additional financial metrics for Eli Lilly and Company.
| Collaboration and Other Revenue | 3078600000 |
|---|---|
| Product | 25462800000 |
| Collaboration and Other Revenue | 5310200000 |
|---|---|
| Product | 28813900000 |
| Collaboration and Other Revenue | 4294800000 |
|---|---|
| Product | 40747900000 |
The above chart shows Eli Lilly and Company's revenue percentage share by segment (products and services).
In fiscal year 2022, Eli Lilly and Company's revenue by segment is as follows:
- Collaboration and Other Revenue generated $3.08 B in revenue, representing 10.79% of its total revenue.
- Product generated $25.46 B in revenue, representing 89.21% of its total revenue.
The biggest segment for Eli Lilly and Company is the Product, which represents 89.21% of its total revenue.
The smallest segment for Eli Lilly and Company is the Collaboration and Other Revenue, which represents 10.79% of its total revenue.
The above chart shows Eli Lilly and Company's revenue percentage share by segment (products and services).
In fiscal year 2023, Eli Lilly and Company's revenue by segment is as follows:
- Collaboration and Other Revenue generated $5.31 B in revenue, representing 15.56% of its total revenue.
- Product generated $28.81 B in revenue, representing 84.44% of its total revenue.
The biggest segment for Eli Lilly and Company is the Product, which represents 84.44% of its total revenue.
The smallest segment for Eli Lilly and Company is the Collaboration and Other Revenue, which represents 15.56% of its total revenue.
The above chart shows Eli Lilly and Company's revenue percentage share by segment (products and services).
In fiscal year 2024, Eli Lilly and Company's revenue by segment is as follows:
- Collaboration and Other Revenue generated $4.29 B in revenue, representing 9.53% of its total revenue.
- Product generated $40.75 B in revenue, representing 90.47% of its total revenue.
The biggest segment for Eli Lilly and Company is the Product, which represents 90.47% of its total revenue.
The smallest segment for Eli Lilly and Company is the Collaboration and Other Revenue, which represents 9.53% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Collaboration and Other Revenue | 10.79% | 15.56% | 9.53% |
| Product | 89.21% | 84.44% | 90.47% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Eli Lilly and Company.
In fiscal year 2024, the Product generated the most revenue ($40.75 B), and the Collaboration and Other Revenue generated the least revenue ($4.29 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Related
-
Agilent Technologies Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
